Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation

Patella-Dislocation Clinical Trial

Official title: PRP Treatment for Medial Retinaculum Tear - Randomized-Double-Blind-Placebo Control Trail

Status Completed

Clinical Trial Summary

To check the influence of injected platelet-rich plasma (PRP) on the healing of medial retinaculum and the redaction in recurrent dislocation of the patella.

Clinical Trial Description

Autologous platelet-rich matrices may aid in the healing of ligaments & tendons by promoting and accelerating tissue healing because of the release of growth factors including transforming growth factor (TGF)-beta1 and platelet-derived growth factor (PDGF) from platelet alpha-granules. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Dislocations
• Patella-Dislocation
• Patellar Dislocation

• NCT number: NCT00743873
• Study type: Interventional
• Source: Meir Medical Center
• Status: Completed
• Phase: Phase 2/Phase 3
• Start date: January 2008
• Completion date: March 2009